These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9398846)

  • 41. Possible key role for plasmin in the pathogenesis of abdominal aortic aneurysms.
    Jean-Claude J; Newman KM; Li H; Gregory AK; Tilson MD
    Surgery; 1994 Aug; 116(2):472-8. PubMed ID: 8048013
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Direct stimulation of urokinase, plasmin, and collagenase by meperidine: a possible mechanism for the ability of meperidine to enhance cervical effacement and dilation.
    Milwidsky A; Finci-Yeheskel Z; Mayer M
    Am J Perinatol; 1993 Mar; 10(2):130-4. PubMed ID: 8476475
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [Autocrine-generated matrix metalloproteinases of tumor cells and the cascade network of protease activation mediated by membrane associated urokinase-type plasminogen activator: involvement in the degradation of extracellular matrices].
    Takahashi K
    Rinsho Byori; 1997 Feb; Suppl 104():159-69. PubMed ID: 9128377
    [No Abstract]   [Full Text] [Related]  

  • 44. Abnormal expression of plasminogen activators in aortic aneurysmal and occlusive disease.
    Reilly JM; Sicard GA; Lucore CL
    J Vasc Surg; 1994 May; 19(5):865-72. PubMed ID: 8170041
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Inflammation and matrix metalloproteinases in the enlarging abdominal aortic aneurysm.
    Freestone T; Turner RJ; Coady A; Higman DJ; Greenhalgh RM; Powell JT
    Arterioscler Thromb Vasc Biol; 1995 Aug; 15(8):1145-51. PubMed ID: 7627708
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Persistence of plasmin-mediated pro-urokinase activation on the surface of human monocytoid leukemia cells in vitro.
    Tapiovaara H; Stephens RW; Vaheri A
    Int J Cancer; 1993 Feb; 53(3):499-505. PubMed ID: 8428801
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Degradation of glycoprotein and collagenous components of the basement membrane: studies with urokinase-type plasminogen activator, alpha-thrombin, and plasmin.
    Goldfarb RH; Murano G; Brundage R; Siegal GP; Terranova V; Garbisa S; Liotta LA
    Semin Thromb Hemost; 1986 Oct; 12(4):335-6. PubMed ID: 2947330
    [No Abstract]   [Full Text] [Related]  

  • 48. Increased medial degradation with pseudo-aneurysm formation in apolipoprotein E-knockout mice deficient in tissue inhibitor of metalloproteinases-1.
    Lemaître V; Soloway PD; D'Armiento J
    Circulation; 2003 Jan; 107(2):333-8. PubMed ID: 12538437
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Cooperation between matrix metalloproteinases and the plasminogen activator-plasmin system in tumor progression.
    DeClerck YA; Laug WE
    Enzyme Protein; 1996; 49(1-3):72-84. PubMed ID: 8796998
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Clearance of plasmin-PN-1 complexes by vascular smooth muscle cells in human aneurysm of the ascending aorta.
    Boukais K; Borges LF; Venisse L; Touat Z; François D; Arocas V; Jondeau G; Declerck P; Bouton MC; Michel JB
    Cardiovasc Pathol; 2018; 32():15-25. PubMed ID: 29149696
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Vascular aneurysms: a perspective.
    Chakraborti S; Chowdhury A; Alam MN; Sarkar J; Mandal A; Pramanik A; Chakraborti T
    Indian J Biochem Biophys; 2014 Dec; 51(6):449-56. PubMed ID: 25823216
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Urokinase-type plasminogen activator and arthritis progression: contrasting roles in systemic and monoarticular arthritis models.
    De Nardo CM; Lenzo JC; Pobjoy J; Hamilton JA; Cook AD
    Arthritis Res Ther; 2010; 12(5):R199. PubMed ID: 20973954
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Matrix metalloproteinases and descending aortic aneurysms: parity, disparity, and switch.
    Theruvath TP; Jones JA; Ikonomidis JS
    J Card Surg; 2012 Jan; 27(1):81-90. PubMed ID: 21958052
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Source of elastin-degrading enzymes in mycotic aortic aneurysms: bacteria or host inflammatory response?
    Buckmaster MJ; Curci JA; Murray PR; Liao S; Allen BT; Sicard GA; Thompson RW
    Cardiovasc Surg; 1999 Jan; 7(1):16-26. PubMed ID: 10073755
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of LHRH-peptidase and plasminogen activator activity in rat testis extracts.
    Hedger MP; Culler MD
    Reprod Fertil Dev; 1997; 9(7):659-64. PubMed ID: 9623484
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Matrilysin-dependent elastolysis by human macrophages.
    Filippov S; Caras I; Murray R; Matrisian LM; Chapman HA; Shapiro S; Weiss SJ
    J Exp Med; 2003 Sep; 198(6):925-35. PubMed ID: 12963695
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The potential role of protease systems in hemophilic arthropathy.
    Hauw WWS; Chia JSJ; Nandurkar HH; Sashindranath M
    Blood Adv; 2022 Sep; 6(18):5505-5515. PubMed ID: 35580335
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Degradation of connective tissue matrices by macrophages. II. Influence of matrix composition on proteolysis of glycoproteins, elastin, and collagen by macrophages in culture.
    Jones PA; Werb Z
    J Exp Med; 1980 Dec; 152(6):1527-36. PubMed ID: 6450258
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Inhibitor of plasminogen activator in human arterial wall. I. Histochemical study.
    Okamura T; Nanno S; Sueishi K; Tanaka K
    Acta Pathol Jpn; 1984 Jul; 34(4):743-7. PubMed ID: 6237546
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Role of the plasminogen/plasmin system in thrombosis, hemostasis, restenosis and atherosclerosis evaluation in transgenic animals.
    Carmeliet P; Collen D
    Trends Cardiovasc Med; 1995; 5(4):117-22. PubMed ID: 21232247
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.